Selecting antagonistic antibodies that control differentiation through inducible expression in embryonic stem cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 44, 2013, Pages 17802-17807

  Melidoni, Anna N ^a,d   Dyson, Michael R ^b   Wormald, Sam ^c,e   McCafferty, John ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b IONTAS LTD   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTOR RECEPTOR 1; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR REX1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CELL LINE; CELL PROLIFERATION; EMBRYO; EMBRYONIC STEM CELL; GENE EXPRESSION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

FUNCTIONAL SCREEN; PHAGE DISPLAY; PHENOTYPIC SELECTION;

ANIMALS; ANTIBODIES; CELL DIFFERENTIATION; CELL LINE; CELL SURFACE DISPLAY TECHNIQUES; DNA PRIMERS; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; GENETIC MARKERS; MICE; POLYMERASE CHAIN REACTION; RNA, UNTRANSLATED; SIGNAL TRANSDUCTION;

EID: 84887037302     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1312062110     Document Type: Article

References (23)

1. Lloyd C, et al. (2009) Modelling the human immune response: Performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens. Protein Eng Des Sel 22(3):159-168.
2. Nelson AL, Dhimolea E, Reichert JM (2010) Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov 9(10):767-774.
3. Edwards BM, et al. (2003) The remarkable flexibility of the human antibody repertoire; Isolation of over one thousand different antibodies to a single protein, BLyS. J Mol Biol 334(1):103-118.
4. Schofield DJ, et al. (2007) Application of phage display to high throughput antibody generation and characterization. Genome Biol 8(11):R254.
5. Zhang H, Wilson IA, Lerner RA (2012) Selection of antibodies that regulate phenotype from intracellular combinatorial antibody libraries. Proc Natl Acad Sci USA 109(39): 15728-15733.
6. Xie J, Zhang H, Yea K, Lerner RA (2013) Autocrine signaling based selection of combinatorial antibodies that transdifferentiate human stem cells. Proc Natl Acad Sci USA 110(20):8099-8104.
7. Murry CE, Keller G (2008) Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132(4):661-680.
8. Schuldiner M, Yanuka O, Itskovitz-Eldor J, Melton DA, Benvenisty N (2000) Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 97(21):11307-11312.
9. Xu X, Browning VL, Odorico JS (2011) Activin, BMP and FGF pathways cooperate to promote endoderm and pancreatic lineage cell differentiation from human embryonic stem cells. Mech Dev 128(7-10):412-427.
10. Vooijs M, Jonkers J, Berns A (2001) A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep 2(4):292-297.
11. Falk R, et al. (2012) Generation of anti-Notch antibodies and their application in blocking Notch signalling in neural stem cells. Methods 58(1):69-78.
12. Kunath T, et al. (2007) FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 134(16):2895-2902.
13. Stavridis MP, Lunn JS, Collins BJ, Storey KG (2007) A discrete period of FGF-induced Erk1/2 signalling is required for vertebrate neural specification. Development 134(16): 2889-2894.
14. Ying QL, et al. (2008) The ground state of embryonic stem cell self-renewal. Nature 453(7194):519-523.
15. Niwa H, Miyazaki J-i, Smith AG (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24(4):372-376.
16. Toyooka Y, Shimosato D, Murakami K, Takahashi K, Niwa H (2008) Identification and characterization of subpopulations in undifferentiated ES cell culture. Development 135(5):909-918.
17. Chambers I, et al. (2007) Nanog safeguards pluripotency and mediates germline development. Nature 450(7173):1230-1234.
18. Bellosta P, et al. (2001) Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis. Mol Cell Biol 21(17):5946-5957.
19. Tang F, et al. (2010) Tracing the derivation of embryonic stem cells from the inner cell mass by single-cell RNA-Seq analysis. Cell Stem Cell 6(5):468-478.
20. Wray J, et al. (2011) Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nat Cell Biol 13(7):838-845.
21. Dyson MR, et al. (2011) Mapping protein interactions by combining antibody affinity maturation and mass spectrometry. Anal Biochem 417(1):25-35.
22. Hartley JL, Temple GF, Brasch MA (2000) DNA cloning using in vitro site-specific recombination. Genome Res 10(11):1788-1795.
23. Hooper M, Hardy K, Handyside A, Hunter S, Monk M (1987) HPRT-deficient (Lesch- Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326(6110):292-295.